The GLAM project, funded by H2020, aims to design and develop a new diagnostic tool to detect biomarkers from biofluids obtained in a non-invasive manner, focusing on urine and genitourinary cancers. It is coordinated by Leitat and involves partners from Spain, the Netherlands, Israel, Belgium, Serbia and the UK.
